Medicare Approves Vivistim Payment Change for 2026
Slice of Healthcare Team
11/26/2025
Key highlights
- Vivistim procedure assigned to APC 1580
- National average payment of approximately $45,000
- Enhanced access for Medicare beneficiaries
- Officially effective January 1, 2026
- Supports sustainable therapy offerings at hospitals
Source: PR Newswire
Notable Quote
“ We are pleased with CMS's decision to assign the Vivistim procedure to New Technology APC 1580, ensuring appropriate reimbursement for this groundbreaking therapy. ”
Richard Foust, President and CEO at MicroTransponder
Why this matters
This classification under Medicare not only facilitates broader access to the innovative Vivistim therapy for stroke recovery but also emphasizes the importance of sustained investment in medical technologies that address critical gaps in patient care. This development is particularly significant for the healthcare sector.
Expert Insights
Share Your Expert Insights
Have relevant experience or professional perspective? Add your thoughtful insights to this article.
